Compelling Reasons for Repairing Human Germlines
Researchers recently reported that, using gene-editing technology, they reduced the proportion of embryos containing a dominant disease allele. Several key advances could result in useful deployment of a high-impact technology that would improve future human health.
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2017-11, Vol.377 (20), p.1909-1911 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1911 |
|---|---|
| container_issue | 20 |
| container_start_page | 1909 |
| container_title | The New England journal of medicine |
| container_volume | 377 |
| creator | Church, George |
| description | Researchers recently reported that, using gene-editing technology, they reduced the proportion of embryos containing a dominant disease allele. Several key advances could result in useful deployment of a high-impact technology that would improve future human health. |
| doi_str_mv | 10.1056/NEJMp1710370 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1965254511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1965254511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-b4b5e035f530dbf3b737a48329e766a7e8a184daa427cd525cb89fb52e7cce683</originalsourceid><addsrcrecordid>eNpt0M9LwzAUB_AgipvTm2cZ6MGD1bzmZ48y5qZMBdFzSNtX6VjamqwH_3szNkXEXBIen3x5fAk5BXoNVMibp-nDYwcKKFN0jwxBMJZwTuU-GVKa6oSrjA3IUQhLGg_w7JAM0gw4gMiGhE5a1-FqVTfv4xe0oW3CuGp9fHe29pvpvHe2Gc_Qu4gwHJODyq4CnuzuEXm7m75O5snieXY_uV0kBeN6neQ8F0iZqASjZV6xXDFluWZphkpKq1Bb0Ly0lqeqKEUqilxnVS5SVEWBUrMRudzmdr796DGsjatDETe1DbZ9MJDJ-IsLgEjP_9Bl2_smbrdRXHIOUkR1tVWFb0PwWJnO1876TwPUbJo0v5uM_GwX2ucOyx_8XV0EF1vgXDANLt3_OV-093cD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1964644165</pqid></control><display><type>article</type><title>Compelling Reasons for Repairing Human Germlines</title><source>MEDLINE</source><source>New England Journal of Medicine Current</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><creator>Church, George</creator><creatorcontrib>Church, George</creatorcontrib><description>Researchers recently reported that, using gene-editing technology, they reduced the proportion of embryos containing a dominant disease allele. Several key advances could result in useful deployment of a high-impact technology that would improve future human health.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMp1710370</identifier><identifier>PMID: 29141159</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Deoxyribonucleic acid ; DNA ; Embryo, Mammalian ; Embryos ; Gene Editing ; Genes ; Genetic Diseases, Inborn - genetics ; Genetic Diseases, Inborn - therapy ; Genetic engineering ; Genetic Engineering - legislation & jurisprudence ; Genetic Therapy ; Genomes ; Germ-Line Mutation ; Humans ; Mutation ; Preventive medicine ; Researchers ; Sperm ; Stem cells ; United States</subject><ispartof>The New England journal of medicine, 2017-11, Vol.377 (20), p.1909-1911</ispartof><rights>Copyright © 2017 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c348t-b4b5e035f530dbf3b737a48329e766a7e8a184daa427cd525cb89fb52e7cce683</citedby><cites>FETCH-LOGICAL-c348t-b4b5e035f530dbf3b737a48329e766a7e8a184daa427cd525cb89fb52e7cce683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMp1710370$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1964644165?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,2759,2760,26103,27924,27925,52382,54064,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29141159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Church, George</creatorcontrib><title>Compelling Reasons for Repairing Human Germlines</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Researchers recently reported that, using gene-editing technology, they reduced the proportion of embryos containing a dominant disease allele. Several key advances could result in useful deployment of a high-impact technology that would improve future human health.</description><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Embryo, Mammalian</subject><subject>Embryos</subject><subject>Gene Editing</subject><subject>Genes</subject><subject>Genetic Diseases, Inborn - genetics</subject><subject>Genetic Diseases, Inborn - therapy</subject><subject>Genetic engineering</subject><subject>Genetic Engineering - legislation & jurisprudence</subject><subject>Genetic Therapy</subject><subject>Genomes</subject><subject>Germ-Line Mutation</subject><subject>Humans</subject><subject>Mutation</subject><subject>Preventive medicine</subject><subject>Researchers</subject><subject>Sperm</subject><subject>Stem cells</subject><subject>United States</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0M9LwzAUB_AgipvTm2cZ6MGD1bzmZ48y5qZMBdFzSNtX6VjamqwH_3szNkXEXBIen3x5fAk5BXoNVMibp-nDYwcKKFN0jwxBMJZwTuU-GVKa6oSrjA3IUQhLGg_w7JAM0gw4gMiGhE5a1-FqVTfv4xe0oW3CuGp9fHe29pvpvHe2Gc_Qu4gwHJODyq4CnuzuEXm7m75O5snieXY_uV0kBeN6neQ8F0iZqASjZV6xXDFluWZphkpKq1Bb0Ly0lqeqKEUqilxnVS5SVEWBUrMRudzmdr796DGsjatDETe1DbZ9MJDJ-IsLgEjP_9Bl2_smbrdRXHIOUkR1tVWFb0PwWJnO1876TwPUbJo0v5uM_GwX2ucOyx_8XV0EF1vgXDANLt3_OV-093cD</recordid><startdate>20171116</startdate><enddate>20171116</enddate><creator>Church, George</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20171116</creationdate><title>Compelling Reasons for Repairing Human Germlines</title><author>Church, George</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-b4b5e035f530dbf3b737a48329e766a7e8a184daa427cd525cb89fb52e7cce683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Embryo, Mammalian</topic><topic>Embryos</topic><topic>Gene Editing</topic><topic>Genes</topic><topic>Genetic Diseases, Inborn - genetics</topic><topic>Genetic Diseases, Inborn - therapy</topic><topic>Genetic engineering</topic><topic>Genetic Engineering - legislation & jurisprudence</topic><topic>Genetic Therapy</topic><topic>Genomes</topic><topic>Germ-Line Mutation</topic><topic>Humans</topic><topic>Mutation</topic><topic>Preventive medicine</topic><topic>Researchers</topic><topic>Sperm</topic><topic>Stem cells</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Church, George</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Church, George</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Compelling Reasons for Repairing Human Germlines</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2017-11-16</date><risdate>2017</risdate><volume>377</volume><issue>20</issue><spage>1909</spage><epage>1911</epage><pages>1909-1911</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Researchers recently reported that, using gene-editing technology, they reduced the proportion of embryos containing a dominant disease allele. Several key advances could result in useful deployment of a high-impact technology that would improve future human health.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>29141159</pmid><doi>10.1056/NEJMp1710370</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2017-11, Vol.377 (20), p.1909-1911 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1965254511 |
| source | MEDLINE; New England Journal of Medicine Current; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland |
| subjects | Deoxyribonucleic acid DNA Embryo, Mammalian Embryos Gene Editing Genes Genetic Diseases, Inborn - genetics Genetic Diseases, Inborn - therapy Genetic engineering Genetic Engineering - legislation & jurisprudence Genetic Therapy Genomes Germ-Line Mutation Humans Mutation Preventive medicine Researchers Sperm Stem cells United States |
| title | Compelling Reasons for Repairing Human Germlines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T23%3A26%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Compelling%20Reasons%20for%20Repairing%20Human%20Germlines&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Church,%20George&rft.date=2017-11-16&rft.volume=377&rft.issue=20&rft.spage=1909&rft.epage=1911&rft.pages=1909-1911&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMp1710370&rft_dat=%3Cproquest_cross%3E1965254511%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1964644165&rft_id=info:pmid/29141159&rfr_iscdi=true |